Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Non-cash Items (2022 - 2025)

Mangoceuticals' Non-cash Items history spans 4 years, with the latest figure at $655277.0 for Q4 2025.

  • On a quarterly basis, Non-cash Items rose 318.26% to $655277.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $655277.0, a 318.26% increase, with the full-year FY2025 number at $655277.0, up 318.26% from a year prior.
  • Non-cash Items hit $655277.0 in Q4 2025 for Mangoceuticals, roughly flat from $654444.0 in the prior quarter.
  • Over the last five years, Non-cash Items for MGRX hit a ceiling of $2.0 million in Q2 2024 and a floor of $133333.0 in Q4 2022.
  • Historically, Non-cash Items has averaged $574351.6 across 4 years, with a median of $261249.5 in 2023.
  • Biggest five-year swings in Non-cash Items: soared 472.29% in 2024 and later plummeted 92.38% in 2025.
  • Tracing MGRX's Non-cash Items over 4 years: stood at $133333.0 in 2022, then soared by 32.5% to $176666.0 in 2023, then fell by 11.32% to $156666.0 in 2024, then surged by 318.26% to $655277.0 in 2025.
  • Business Quant data shows Non-cash Items for MGRX at $655277.0 in Q4 2025, $654444.0 in Q3 2025, and $150833.0 in Q2 2025.